Economic burden of leukemia diagnosis and treatment in South Africa: A retrospective cost of illness analysis.

Clinical and immune features associated with chromosome 13q deletion and PRKCSH downregulation in newly diagnosed multiple myeloma.

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.

Detection of BCR::ABL1-like ALL using RT-PCR, a targeted RNA panel, and RNA sequencing.

Chronic neutrophilic leukemia with transformation to B-lymphoblastic leukemia.

Economic burden of leukemia diagnosis and treatment in South Africa: A retrospective cost of illness analysis.

Clinical and immune features associated with chromosome 13q deletion and PRKCSH downregulation in newly diagnosed multiple myeloma.

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.

Detection of BCR::ABL1-like ALL using RT-PCR, a targeted RNA panel, and RNA sequencing.

Chronic neutrophilic leukemia with transformation to B-lymphoblastic leukemia.